4572 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 13
00:11 UTC
|
ALSN
Allison Transmission
|
↑ Upgrade | Kyle Menges ★★☆☆☆ #2405 | Neutral→ Buy | $135.00 |
|
Oct 13
00:11 UTC
|
ALL
Allstate
|
↑ Upgrade | Elyse Greenspan ★★★★☆ #899 | Underweight→ Equal Weight | $250.00→ $236.00-5.6% |
|
Oct 12
17:10 UTC
|
MANH
Manhattan Associates
|
↑ Upgrade | Chris Quintero ★★★☆☆ #1569 | Equal Weight→ Overweight | $180.00→ $250.00+38.9% |
|
Oct 12
14:10 UTC
|
TYL
Tyler Technologies
|
↑ Upgrade | Michael Turrin ★★★☆☆ #1213 | Equal Weight→ Overweight | $335.00→ $400.00+19.4% |
|
Oct 12
14:10 UTC
|
CWK
Cranswick
|
↑ Upgrade | firm only | Buy | GBX 6,600 |
|
Oct 12
14:10 UTC
|
BXDC
Blackstone Digital Infrastructure Trust
|
↑ Upgrade | Michael Rollins ★★★☆☆ #2056 | Neutral→ Buy | $23.00→ $20.00-13.0% |
|
Oct 12
14:10 UTC
|
ALL
Allstate
|
↑ Upgrade | Elyse Greenspan ★★★★☆ #899 | Underweight→ Equal Weight | $250.00→ $236.00-5.6% |
|
Oct 12
13:10 UTC
|
TYL
Tyler Technologies
|
↑ Upgrade | firm only | Equal Weight→ Overweight | $400.00 |
|
Oct 12
13:10 UTC
|
RDY
Dr. Reddy's Laboratories
|
↑ Upgrade | Tausif Shaikh not yet tracked | Outperform | $14.80 |
|
Oct 12
13:10 UTC
|
MANH
Manhattan Associates
|
↑ Upgrade | Chris Quintero ★★★☆☆ #1569 | Equal Weight→ Overweight | $250.00 |
|
Oct 12
13:10 UTC
|
BXDC
Blackstone Digital Infrastructure Trust
|
↑ Upgrade | Michael Rollins ★★★☆☆ #2056 | Neutral→ Buy | $20.00 |
|
Oct 12
13:10 UTC
|
BRO
Brown & Brown
|
↑ Upgrade | Meyer Shields ★★★☆☆ #1233 | Underperform→ Outperform | $77.00 |
|
Oct 12
13:10 UTC
|
BMRN
BioMarin Pharmaceutical
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | $109.00 |
|
Oct 12
13:10 UTC
|
BIIB
Biogen
|
↑ Upgrade | Chris Schott ★★★☆☆ #1362 | Neutral→ Overweight | $210.00→ $300.00+42.9% |
|
Oct 12
13:10 UTC
|
ALSN
Allison Transmission
|
↑ Upgrade | Kyle Menges ★★☆☆☆ #2405 | Neutral→ Buy | $135.00 |
|
Oct 12
13:10 UTC
|
ALL
Allstate
|
↑ Upgrade | Elyse Greenspan ★★★★☆ #899 | Underweight→ Equal Weight | $236.00 |
|
Oct 12
12:09 UTC
|
TYL
Tyler Technologies
|
↑ Upgrade | firm only | Market Outperform→ Overweight | |
|
Oct 12
12:09 UTC
|
TRNO
Terreno Realty
|
↑ Upgrade | firm only | Market Perform→ Outperform | $75.00 |
|
Oct 12
12:09 UTC
|
TMUS
T-Mobile US
|
↑ Upgrade | Ric Prentiss ★★★☆☆ #2236 | Market Perform→ Outperform | $170.00 |
|
Oct 12
12:09 UTC
|
RDY
Dr. Reddy's Laboratories
|
↑ Upgrade | firm only | Outperform | |
|
Oct 12
12:09 UTC
|
LBRX
LB Pharmaceuticals
|
↑ Upgrade | firm only | Buy | |
|
Oct 12
12:09 UTC
|
HUM
Humana
|
↑ Upgrade | John Ransom ★★★★☆ #758 | Market Perform→ Outperform | $520.00 |
|
Oct 12
12:09 UTC
|
HUBG
Hub Group
|
↑ Upgrade | Daniel Moore ★☆☆☆☆ #3163 | Neutral→ Outperform | $29.00 |
|
Oct 12
12:09 UTC
|
CRM
Salesforce
|
↑ Upgrade | Tal Liani ★★★☆☆ #1541 | Underperform→ Buy | $160.00→ $285.00+78.1% |
|
Oct 12
12:09 UTC
|
ASTS
AST SpaceMobile
|
↑ Upgrade | Bryan Kraft ★★★☆☆ #1560 | Hold→ Buy | $93.00 |
|
Oct 12
12:09 UTC
|
ALL
Allstate
|
↑ Upgrade | Elyse Greenspan ★★★★☆ #899 | Underweight→ Underperform | $236.00 |
|
Oct 12
11:09 UTC
|
TRNO
Terreno Realty
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Oct 12
11:09 UTC
|
BXDC
Blackstone Digital Infrastructure Trust
|
↑ Upgrade | Michael Rollins ★★★☆☆ #2056 | Neutral→ Buy | |
|
Oct 12
11:09 UTC
|
BX
Blackstone
|
↑ Upgrade | firm only | Market Outperform→ Buy | |
|
Oct 12
11:09 UTC
|
BRO
Brown & Brown
|
↑ Upgrade | Meyer Shields ★★★☆☆ #1233 | Underperform→ Outperform | |
|
Oct 12
11:09 UTC
|
BMRN
BioMarin Pharmaceutical
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | |
|
Oct 12
11:09 UTC
|
ALSN
Allison Transmission
|
↑ Upgrade | Kyle Menges ★★☆☆☆ #2405 | Neutral→ Buy | |
|
Oct 12
11:09 UTC
|
ALL
Allstate
|
↑ Upgrade | Elyse Greenspan ★★★★☆ #899 | Underweight→ Underperform | |
|
Oct 12
10:09 UTC
|
MANH
Manhattan Associates
|
↑ Upgrade | Chris Quintero ★★★☆☆ #1569 | Negative→ Overweight | $250.00 |
|
Oct 12
09:09 UTC
|
MANH
Manhattan Associates
|
↑ Upgrade | Chris Quintero ★★★☆☆ #1569 | Negative→ Overweight | |
|
Oct 10
13:20 UTC
|
HUM
Humana
|
↑ Upgrade | Michael Ha ★★★★★ #191 | Hold→ Outperform | $596.00 |
|
Oct 10
12:19 UTC
|
YSS
York Space Systems
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Hold | |
|
Oct 10
12:19 UTC
|
VLPNY
Voestalpine
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Oct 10
12:19 UTC
|
SZGPY
Salzgitter
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Oct 10
12:19 UTC
|
SPCX
SpaceX
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Strong-Buy | |
|
Oct 10
12:19 UTC
|
RTX
RTX
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Strong-Buy | |
|
Oct 10
12:19 UTC
|
RKLB
Rocket Lab
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Strong-Buy | |
|
Oct 10
12:19 UTC
|
PLTR
Palantir Technologies
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Strong-Buy | |
|
Oct 10
12:19 UTC
|
PL
Planet Labs PBC
|
↑ Upgrade | firm only | Hold | |
|
Oct 10
12:19 UTC
|
NOC
Northrop Grumman
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Strong Sell | |
|
Oct 10
12:19 UTC
|
MPB
Mid Penn Bancorp
|
↑ Upgrade | Manuel Navas ★★★★★ #230 | Strong-Buy | $42.00 |
|
Oct 10
12:19 UTC
|
MCRUF
Morgan Advanced Materials
|
↑ Upgrade | firm only | Hold→ Moderate Buy | |
|
Oct 10
12:19 UTC
|
LMT
Lockheed Martin
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Hold | |
|
Oct 10
12:19 UTC
|
LBRX
LB Pharmaceuticals
|
↑ Upgrade | Sumant Kulkarni ★★☆☆☆ #2301 | Strong-Buy | $65.00 |
|
Oct 10
12:19 UTC
|
KTOS
Kratos Defense & Security Solutions
|
↑ Upgrade | Anthony Valentini ★★☆☆☆ #2609 | Strong-Buy |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.